Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 11.

Wirsching, Hans-Georg; Richter, Johannes Konstantin; Sahm, Felix; Morel, Corinne; Krayenbuehl, Niklaus; Rushing, Elisabeth Jane; von Deimling, Andreas; Valavanis, Antonios; Weller, Michael (2018). Post-operative cardiovascular complications and time to recurrence in meningioma patients treated with versus without pre-operative embolization: a retrospective cohort study of 741 patients. Journal of Neuro-Oncology, 140(3):659-667.

Sievers, Philipp; Stichel, Damian; Hielscher, Thomas; et al; Wirsching, Hans-Georg (2018). Chordoid meningiomas can be sub-stratified into prognostically distinct DNA methylation classes and are enriched for heterozygous deletions of chromosomal arm 2p. Acta Neuropathologica, 136(6):975-978.

Cimino, Patrick J; McFerrin, Lisa; Wirsching, Hans-Georg; Arora, Sonali; Bolouri, Hamid; Rabadan, Raul; Weller, Michael; Holland, Eric C (2018). Copy number profiling across glioblastoma populations has implications for clinical trial design. Neuro-Oncology, 20(10):1368-1373.

Katz, Leah M; Hielscher, Thomas; Liechty, Benjamin; Silverman, Joshua; Zagzag, David; Sen, Rajeev; Wu, Peter; Golfinos, John G; Reuss, David; Neidert, Marian Christoph; Wirsching, Hans-Georg; Baumgarten, Peter; Herold-Mende, Christel; Wick, Wolfgang; Harter, Patrick N; Weller, Michael; von Deimling, Andreas; Snuderl, Matija; Sen, Chandra; Sahm, Felix (2018). Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence. Acta Neuropathologica, 135(6):955-963.

Schneider, Hannah; Lohmann, Birthe; Wirsching, Hans-Georg; Hasenbach, Kathy; Rushing, Elisabeth J; Frei, Karl; Pruschy, Martin; Tabatabai, Ghazaleh; Weller, Michael (2017). Age-associated and therapy-induced alterations in the cellular microenvironment of experimental gliomas. OncoTarget, 8(50):87124-87135.

Reifenberger, Guido; Wirsching, Hans-Georg; Knobbe-Thomsen, Christiane B; Weller, Michael (2017). Advances in the molecular genetics of gliomas - implications for classification and therapy. Nature Reviews. Clinical Oncology, 14(7):434-452.

Cimino, Patrick J; Zager, Michael; McFerrin, Lisa; Wirsching, Hans-Georg; Bolouri, Hamid; Hentschel, Bettina; von Deimling, Andreas; Jones, David; Reifenberger, Guido; Weller, Michael; Holland, Eric C (2017). Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery. Acta Neuropathologica Communications, 5(1):39.

Sahm, Felix; Schrimpf, Daniel; Stichel, Damian; Jones, David T W; Hielscher, Thomas; Schefzyk, Sebastian; Okonechnikov, Konstantin; Koelsche, Christian; Reuss, David E; Capper, David; Sturm, Dominik; Wirsching, Hans-Georg; Berghoff, Anna Sophie; Baumgarten, Peter; Kratz, Annekathrin; Huang, Kristin; Wefers, Annika K; Hovestadt, Volker; Sill, Martin; Ellis, Hayley P; Kurian, Kathreena M; Okuducu, Ali Fuat; Jungk, Christine; Drueschler, Katharina; Schick, Matthias; Bewerunge-Hudler, Melanie; Mawrin, Christian; Seiz-Rosenhagen, Marcel; Ketter, Ralf; Simon, Matthias; et al (2017). DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncology, 18(5):682-694.

Wirsching, Hans-Georg; Morel, Corinne; Gmür, Corinne; Neidert, Marian Christoph; Baumann, Christian Richard; Valavanis, Antonios; Rushing, Elisabeth Jane; Krayenbühl, Niklaus; Weller, Michael (2016). Predicting outcome of epilepsy after meningioma resection. Neuro-Oncology, 18(7):1002-1010.

Wirsching, Hans-Georg; Tritschler, Isabel; Palla, Antonella; Renner, Christoph; Weller, Michael; Tabatabai, Ghazaleh (2014). The management of lomustine overdose in malignant glioma patients. Neuro-Oncology Practice, 1(4):178-183.

Wirsching, Hans-Georg; Krishnan, Shanmugarajan; Florea, Ana-Maria; Frei, Karl; Krayenbühl, Niklaus; Hasenbach, Kathy; Reifenberger, Guido; Weller, Michael; Tabatabai, Ghazaleh (2014). Thymosin beta 4 gene silencing decreases stemness and invasiveness in glioblastoma. Brain, 137(2):433-448.

This list was generated on Wed Jun 19 09:37:11 2019 CEST.